In a groundbreaking shift, CVS has announced a significant change to its drug pricing formula, aimed at enhancing transparency and simplifying costs for consumers. This strategic adjustment is ...
Though the company says the model will not increase the cost of drugs, some experts have said that how CVS calculates the acquisition cost of drugs, and how it negotiates mark-ups with payers ...
A new report issued by the Federal Trade Commission has found that prescription benefit manager units owned by CVS Health (NYSE:CVS), Cigna (CI) and UnitedHealth Group (UNH) significantly marked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback